Nyxoah SA Change in Accounts Receivable 2021-2025 | NYXH
Nyxoah SA change in accounts receivable from 2021 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
| Nyxoah SA Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $-1 |
| 2023 | $-2 |
| 2022 | $0 |
| 2021 | $-3 |
| 2020 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.264B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.946B | 59.99 |
| Hims & Hers Health (HIMS) | United States | $12.884B | 133.86 |
| Tempus AI (TEM) | United States | $12.253B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.705B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.914B | 61.16 |
| Privia Health (PRVA) | United States | $2.805B | 191.75 |
| Hinge Health (HNGE) | United States | $2.743B | 0.00 |
| Schrodinger (SDGR) | United States | $1.958B | 0.00 |
| Enovis (ENOV) | United States | $1.904B | 10.62 |
| Phreesia (PHR) | United States | $1.677B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Omnicell (OMCL) | United States | $1.424B | 25.12 |
| Azenta (AZTA) | United States | $1.410B | 65.55 |
| 10x Genomics (TXG) | United States | $1.327B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.661B | 0.00 |
| Claritev (CTEV) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.623B | 0.00 |
| Talkspace (TALK) | United States | $0.518B | 154.75 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.67 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.276B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 3.61 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |